Cargando…

Fasudil attenuates aggregation of α-synuclein in models of Parkinson’s disease

Parkinson’s disease (PD) is the most common neurodegenerative movement disorder, yet disease-modifying treatments do not currently exist. Rho-associated protein kinase (ROCK) was recently described as a novel neuroprotective target in PD. Since alpha-synuclein (α-Syn) aggregation is a major hallmark...

Descripción completa

Detalles Bibliográficos
Autores principales:	Tatenhorst, Lars, Eckermann, Katrin, Dambeck, Vivian, Fonseca-Ornelas, Luis, Walle, Hagen, Lopes da Fonseca, Tomás, Koch, Jan C., Becker, Stefan, Tönges, Lars, Bähr, Mathias, Outeiro, Tiago F., Zweckstetter, Markus, Lingor, Paul
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2016
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4840958/ https://www.ncbi.nlm.nih.gov/pubmed/27101974 http://dx.doi.org/10.1186/s40478-016-0310-y

Ejemplares similares

Deferiprone Rescues Behavioral Deficits Induced by Mild Iron Exposure in a Mouse Model of Alpha-Synuclein Aggregation
por: Carboni, Eleonora, et al.
Publicado: (2017)

Alpha-synuclein mutations impair axonal regeneration in models of Parkinson's disease
por: Tönges, Lars, et al.
Publicado: (2014)

Increased alpha-synuclein tear fluid levels in patients with Parkinson’s disease
por: Maass, Fabian, et al.
Publicado: (2020)

Rho Kinase Inhibition with Fasudil in the SOD1(G93A) Mouse Model of Amyotrophic Lateral Sclerosis—Symptomatic Treatment Potential after Disease Onset
por: Günther, René, et al.
Publicado: (2017)

Inhibition of rho kinase enhances survival of dopaminergic neurons and attenuates axonal loss in a mouse model of Parkinson’s disease
por: Tönges, Lars, et al.
Publicado: (2012)

ROCKing Regeneration: Rho Kinase Inhibition as Molecular Target for Neurorestoration
por: Tönges, Lars, et al.
Publicado: (2011)

Axonal degeneration as a therapeutic target in the CNS
por: Lingor, Paul, et al.
Publicado: (2012)

Compassionate Use of the ROCK Inhibitor Fasudil in Three Patients With Amyotrophic Lateral Sclerosis
por: Koch, Jan C., et al.
Publicado: (2020)

AAV-mediated inhibition of ULK1 promotes axonal regeneration in the central nervous system in vitro and in vivo
por: Ribas, Vinicius Toledo, et al.
Publicado: (2021)

Viral vector-mediated downregulation of RhoA increases survival and axonal regeneration of retinal ganglion cells
por: Koch, Jan Christoph, et al.
Publicado: (2014)

miR-182-5p and miR-183-5p Act as GDNF Mimics in Dopaminergic Midbrain Neurons
por: Roser, Anna-Elisa, et al.
Publicado: (2018)

Alpha-Synuclein affects neurite morphology, autophagy, vesicle transport and axonal degeneration in CNS neurons
por: Koch, J C, et al.
Publicado: (2015)

JNK Isoforms Differentially Regulate Neurite Growth and Regeneration in Dopaminergic Neurons In Vitro
por: Tönges, Lars, et al.
Publicado: (2011)

Aggregation of αSynuclein promotes progressive in vivo neurotoxicity in adult rat dopaminergic neurons
por: Taschenberger, Grit, et al.
Publicado: (2011)

Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization
por: Dominguez-Meijide, Antonio, et al.
Publicado: (2020)

Sumoylation inhibits α-synuclein aggregation and toxicity
por: Krumova, Petranka, et al.
Publicado: (2011)

Small Molecules Detected by Second-Harmonic Generation Modulate the Conformation of Monomeric α-Synuclein and Reduce Its Aggregation in Cells
por: Moree, Ben, et al.
Publicado: (2015)

Alpha‐synuclein fibrils amplified from multiple system atrophy and Parkinson's disease patient brain spread after intracerebral injection into mouse brain
por: Zhang, Shuyu, et al.
Publicado: (2023)

Propionic Acid and Fasudil as Treatment against Rotenone Toxicity in an In Vitro Model of Parkinson’s Disease
por: Ostendorf, Friederike, et al.
Publicado: (2020)

Low-Expressing Synucleinopathy Mouse Models Based on Oligomer-Forming Mutations and C-Terminal Truncation of α-Synuclein
por: Martinez Hernandez, Ana, et al.
Publicado: (2021)

Inhibition of the autophagic protein ULK1 attenuates axonal degeneration in vitro and in vivo, enhances translation, and modulates splicing
por: Vahsen, Björn Friedhelm, et al.
Publicado: (2020)

The rho kinase inhibitor Y-27632 improves motor performance in male SOD1(G93A) mice
por: Günther, René, et al.
Publicado: (2014)

ATP13A2 and Alpha-synuclein: a Metal Taste in Autophagy
por: Lopes da Fonseca, Tomás, et al.
Publicado: (2014)

The Interplay between Alpha-Synuclein Clearance and Spreading
por: Lopes da Fonseca, Tomás, et al.
Publicado: (2015)

Small Molecule Fisetin Modulates Alpha–Synuclein Aggregation
por: Rosado-Ramos, Rita, et al.
Publicado: (2021)

Protein phosphorylation in neurodegeneration: friend or foe?
por: Tenreiro, Sandra, et al.
Publicado: (2014)

ROCK2 is a major regulator of axonal degeneration, neuronal death and axonal regeneration in the CNS
por: Koch, J C, et al.
Publicado: (2014)

Endogenous Levels of Alpha-Synuclein Modulate Seeding and Aggregation in Cultured Cells
por: Vasili, Eftychia, et al.
Publicado: (2022)

Genipin prevents alpha-synuclein aggregation and toxicity by affecting endocytosis, metabolism and lipid storage
por: Rosado-Ramos, Rita, et al.
Publicado: (2023)

Modulation of Microglial Activity by Rho-Kinase (ROCK) Inhibition as Therapeutic Strategy in Parkinson’s Disease and Amyotrophic Lateral Sclerosis
por: Roser, Anna-Elisa, et al.
Publicado: (2017)

Alpha-Synuclein Antibody Characterization: Why Semantics Matters
por: Outeiro, Tiago Fleming
Publicado: (2021)

Blood Contamination in CSF and Its Impact on Quantitative Analysis of Alpha-Synuclein
por: Barkovits, Katalin, et al.
Publicado: (2020)

Identification of Two Novel Peptides That Inhibit α-Synuclein Toxicity and Aggregation
por: Popova, Blagovesta, et al.
Publicado: (2021)

Calpain-mediated cleavage of collapsin response mediator protein-2 drives acute axonal degeneration
por: Zhang, Jian-Nan, et al.
Publicado: (2016)

Drug Targeting of α-Synuclein Oligomerization in Synucleinopathies
por: Outeiro, Tiago Fleming, et al.
Publicado: (2008)

Tau Enhances α-Synuclein Aggregation and Toxicity in Cellular Models of Synucleinopathy
por: Badiola, Nahuai, et al.
Publicado: (2011)

The effects of the novel A53E alpha-synuclein mutation on its oligomerization and aggregation
por: Lázaro, Diana F., et al.
Publicado: (2016)

Chicago sky blue 6B inhibits α-synuclein aggregation and propagation
por: Min, Joo-Ok, et al.
Publicado: (2022)

Assessing the Subcellular Dynamics of Alpha-synuclein Using Photoactivation Microscopy
por: Gonçalves, Susana, et al.
Publicado: (2013)

Alpha-Synuclein: Mechanisms of Release and Pathology Progression in Synucleinopathies
por: Brás, Inês C., et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_m58lndpmbff7e60puoo9g3093e